Abbott to Expand Its Cancer Diagnostic Segment
Abbott recently announced that it agreed to acquire Exact Sciences for approximately $21 billion to enter the fast-growing cancer diagnostic segment. Under the terms of the agreement, Abbott will acquire all outstanding shares of...
How to Measure Performance for AI-Enabled Medical Devices? FDA Seeks Public Input
On September 30, 2025, the U.S. Food and Drug Administration (FDA ) posted a Request for Public Comment regarding how to measure the performance of medical devices enabled with artificial intelligence (AI). The...
Knobbe Martens Guides X-Ray Technology Pioneer Sigray to Success in Patent and Trade Secret Jury Trial
IRVINE, Calif., September 10, 2025 – A trial team from Knobbe Martens secured a significant success on behalf of innovator Sigray, Inc. in an IP dispute involving groundbreaking x-ray technologies....